[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371959-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-371959-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","bone-metastases-from-endocrine-cancer-advances-in-diagnosis-treatment-and-prevention","Bone metastases from endocrine cancer - advances in diagnosis, treatment, and prevention","","Endocrine cancers frequently metastasize hematogenously to bone, and improved imaging plus longer patient survival has increased detection rates. Despite this, accurate diagnosis remains difficult due to heterogeneous metastatic mechanisms across endocrine tumor types and high therapeutic resistance. Preventive measures are still inadequate and clinical management often lacks integration. This review synthesizes recent progress in diagnosis, management, and prevention, proposing an integrated diagnostic paradigm combining clinical assessment, advanced imaging, and molecular or genomic profiling to support precision medicine.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/bone-metastases-from-endocrine-cancer-advances-in-diagnosis-treatment-and-prevention/371959/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/bone-metastases-from-endocrine-cancer-advances-in-diagnosis-treatment-and-prevention/371959.png","ImageObject",300,407,{"name":42,"@type":43},"OmBimo","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is diagnosing bone metastases in endocrine cancer challenging?","Question",{"text":63,"@type":64},"Diagnosis is complicated by heterogeneous metastatic mechanisms across cancer types and by high rates of therapeutic resistance.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What does the review emphasize for improving diagnostic accuracy?",{"text":68,"@type":64},"It highlights an integrated diagnostic paradigm that combines clinical assessment, advanced imaging, and molecular/genomic profiling.",{"name":70,"@type":61,"acceptedAnswer":71},"How do bone metastases affect patients with endocrine malignancies?",{"text":72,"@type":64},"Bone metastases cause significant morbidity through skeletal-related events such as pathological fractures, spinal cord compression, and intractable pain, which worsens quality of life and survival.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371959,1790450357,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962090893581,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","TYPE Review  \nPUBLISHED 12 December 2025 DOI 10.3389/fendo.2025.1669154  \nOPEN ACCESS  \nEDITED BY  \nChandi C. Mandal,  \nCentral University of Rajasthan, India  \nREVIEWED BY  \nAnna La Salvia,  \nNational Institute of Health (ISS), Italy Duoyi Zhao,  \nFourth Afﬁliated Hospital of China Medical University, China  \n*CORRESPONDENCE  \nLaijian Sui  \n [herrsui@126.com](herrsui@126.com)  \nRECEIVED 19 July 2025  \nREVISED 28 October 2025  \nACCEPTED 26 November 2025  \nPUBLISHED 12 December 2025  \nCITATION  \nHuang S, Shen Y, Li H, Geng T, Yan J, Wang Land Sui L (2025) Bone metastases from endocrine cancer: advances in diagnosis, treatment, and prevention.  \nFront. Endocrinol. 16:1669154 .  \ndoi: 10.3389/fendo.2025.1669154  \nCOPYRIGHT  \n© 2025 Huang, Shen, Li, Geng, Yan, Wang and Sui. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nBone metastases from endocrine cancer: advances in diagnosis, treatment, and prevention  \nShuzhou Huang 1,2, Yue Shen 2,3, Hanchen Li 1, Tianxiang Geng 2, Jinhong Yan 2, Li Wang 4 and Laijian Sui 2*  \n1 Department of Orthopedics, Shandong Second Medical University, Weifang, Shandong, China,  \n2 Department of Orthopedics, Yantai Yuhuangding Hospital, Yantai, Shandong, China, 3 Department of Orthopedics, Binzhou Medical University, Yantai, Shandong, China, 4 Department of Neurology, Afﬁliated Hospital of Qingdao University, Qingdao, Shandong, China  \nEndocrine cancers, originating from hormone-producing organs, prefer to metastasize hematogenously to bone as a common site. Once considered rare, diagnosis rate of bone metastases presents a rising trend attribute to advanced imaging techniques and greater patient longevity. However, accurate diagnosis of bone metastases remains challenging. Diagnostic hurdles stem from heterogeneous metastatic mechanisms among cancer types and high rates of therapeutic resistance. Preventive measures remain sub-optimal, and clinical management pathways are often fragmented. Addressing these complexities requires a systematic research approach to enhance diagnostic accuracy and optimize therapeutic strategies. Present review synthesizes recent progress in the diagnosis, management, and prevention of bone metastases in endocrine tumors, emphasizing the imperative for an integrated diagnostic paradigm that leverages clinical assessment, advanced imaging, and molecular/genomic proﬁling to inform precision medicine. We also explore emerging hybrid predictive models that clarify the distinct biological mechanisms underpinning bone metastasis in various endocrine cancers. Ultimately, this review identiﬁes pathways for improved therapies, reﬁned clinical guidelines, and enhanced multidisciplinary collaboration, aiming to extend survival, improve quality of life, and ensure optimal healthcare resource utilization for patients with endocrine malignancies.  \nKEYWORDS  \nendocrine cancer, bone metastasis, cross-cancer mechanism, diagnosis, treatment, prevention  \n1 Introduction  \nEndocrine cancers comprise a diverse group of malignancies arising from hormoneproducing tissues or hormone-dependent cells, which are typically divided into classical endocrine gland cancers, neuroendocrine tumors (NETs), and endocrine-dependent cancers (1) . Among them, thyroid cancer is the most prevalent endocrine malignancies  \nFrontiers in Endocrinology 01 [frontiersin.org](frontiersin.org)  \nrepresenting over 90% . Its global incidence is rising steadily, attributing to improved screening and diagnostic awareness (2, 3) . The majority are well-differentiated types—papillary and follicular thyroid carcinoma—which genera","cbCaicb4QsjoV4Wb","https://ap.wps.com/l/cbCaicb4QsjoV4Wb","pdf",2391874,28,"English","# Introduction\n## Thyroid cancer and bone metastasis\n## Neuroendocrine tumors (NETs)\n## Endocrine-dependent cancers and prognosis\n## Clinical impact of skeletal-related events","[{\"question\":\"Why is diagnosing bone metastases in endocrine cancer challenging?\",\"answer\":\"Diagnosis is complicated by heterogeneous metastatic mechanisms across cancer types and by high rates of therapeutic resistance.\"},{\"question\":\"What does the review emphasize for improving diagnostic accuracy?\",\"answer\":\"It highlights an integrated diagnostic paradigm that combines clinical assessment, advanced imaging, and molecular/genomic profiling.\"},{\"question\":\"How do bone metastases affect patients with endocrine malignancies?\",\"answer\":\"Bone metastases cause significant morbidity through skeletal-related events such as pathological fractures, spinal cord compression, and intractable pain, which worsens quality of life and survival.\"}]","Bone metastases from endocrine cancer - advances in diagnosis, treatment, and prevention | PDF",1790193323,71,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2c59aca47b9944c637a104d1a20a7c05.webp",983,1389,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da993191a51a2cce2d6708cf7b47f246.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b526110faa3d4ad879b65feba7e741b2.webp",981,1386,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7582e31dcb1a5fe87f1541412315fc29.webp",980,1385]